Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income	$ 1,841	$ 2,835
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Provision for (recapture of) credit losses	810	(429)
Depreciation	323	573
Amortization of deferred loan origination costs, net	(460)	(376)
Net amortization of premiums and discounts on available-for-sale securities	(511)	192
Amortization of purchase accounting marks on loans	(66)	(990)
Amortization of core deposit intangible	195	217
Accretion of premium on FHLB advances	(6)	(20)
ESOP compensation expense	22	45
Earnings on bank owned life insurance	(20)	(21)
Change in assets and liabilities:
Net change in deferred taxes	461	1,209
Net change in accrued interest receivable	(141)	678
Net change in other assets	(595)	(1,039)
Net change in accrued expenses and other liabilities	97	(3,375)
Net cash provided by (used in) operating activities	2,135	(359)
Cash flows from investing activities:
Net change in loans receivable held for investment	(58,668)	3,440
Principal payments on available-for-sale securities	6,821	9,231
Purchase of available-for-sale securities	0	(104,657)
Purchase of FHLB stock	(3,783)	(328)
Proceeds from redemption of FHLB stock	256	1,431
Proceeds from redemption of FRB stock	1,721	0
Purchase of office properties and equipment	(32)	(583)
Net cash used in investing activities	(53,685)	(91,466)
Cash flows from financing activities:
Net change in deposits	(40,853)	28,125
Net change in securities sold under agreements to repurchase	7,910	15,332
Increase in unreleased ESOP shares	(2,800)	0
Proceeds from issuance of preferred stock	0	150,000
Dividends paid on preferred stock	0	(15)
Proceeds from FHLB advances	82,000	0
Repayments of FHLB advances	(70)	(53,000)
Net cash provided by financing activities	46,187	140,442
Net change in cash and cash equivalents	(5,363)	48,617
Cash and cash equivalents at beginning of the period	16,105	231,520
Cash and cash equivalents at end of the period	10,742	280,137
Supplemental disclosures of cash flow information:
Cash paid for interest	4,648	1,378
Cash paid for income taxes	236	0
Supplemental non-cash disclosures:
Common stock issued in exchange for preferred stock	0	3,000
Directors [Member]
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Stock-based compensation expense	95	84
Employees, Excluding Directors [Member]
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Stock-based compensation expense	$ 90	$ 58